Results 151 to 160 of about 1,438,843 (259)

ANTI-STATISM OF PRIVATE LAW

open access: yesPrivate Law and Business, 2018
openaire   +1 more source

Northern Territory Anti-Discrimination Commission annual report 2004-2005

open access: yes, 2005
Date:2005This publication contains many links to external sites. These external sites may no longer be active.Made available by via the Publications (Legal Deposit) Act 2004 (NT)

core  

First‐in‐human, phase I, randomized, safety, pharmacokinetic, food‐effect and pharmacodynamic study of a tyrosine kinase 2/Janus kinase 1 inhibitor, SDC‐1801

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), food‐effect (FE) and pharmacodynamics (PD) of an oral tyrosine kinase‐2 (TYK2)/Janus kinase‐1 (JAK1) inhibitor, SDC‐1801, in healthy adult participants. Methods This first‐in‐human study randomized 95 male and female participants.
Chris Brearley   +3 more
wiley   +1 more source

Lost and found in translation: the value of the human imiquimod model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Topical imiquimod (IMQ), a Toll‐like receptor (TLR) 7 agonist, induces transient cutaneous inflammation and is widely used in preclinical research as a ‘psoriasis‐like’ mouse model. However, accumulating evidence indicates substantial divergence between IMQ‐driven biology and human plaque psoriasis pathogenesis.
Anouk C. Meijs   +6 more
wiley   +1 more source

Northern Territory Anti-Discrimination Commission annual report 2002-2003

open access: yes, 2003
Date:2003This publication contains many links to external sites. These external sites may no longer be active.Made available by via the Publications (Legal Deposit) Act 2004 (NT)

core  

New opportunities for bioscaffold‐enabled spinal cord injury repair

open access: yesBMEMat, EarlyView.
Schematic illustration of bioscaffolds for spinal cord injury repair. We summarize the effects of bioscaffold properties on SCI repair, highlight different types of bioscaffolds, various fabrication strategies, and in vivo transformations for the clinical development of SCI‐repairing bioscaffolds.
Xiaoqing Qi   +11 more
wiley   +1 more source

Northern Territory Anti-Discrimination Commission annual report 2010-2011

open access: yes, 2011
Date:2011This publication contains many links to external sites. These external sites may no longer be active.Made available by via the Publications (Legal Deposit) Act 2004 (NT)

core  

Deciphering the catalytic and pharmacological mechanisms of Coptis chinensis herbzymes to renovate intestinal microenvironment for colitis alleviation

open access: yesBMEMat, EarlyView.
The synthesized CCzymes possess both antioxidant enzyme activity and pharmacological properties inherent to Coptis chinensis. By their antioxidant enzyme activity, CCzymes can attenuate oxidative stress within the inflammatory region of ulcerative colitis (UC), while their pharmacological activity acts on macrophage polarization and the intestinal ...
Zhichao Deng   +10 more
wiley   +1 more source

Northern Territory Anti-Discrimination Commission annual report 2014-2015

open access: yes, 2015
This publication contains many links to external sites. These external sites may no longer be active.Made available by via the Publications (Legal Deposit) Act 2004 (NT)

core  

Home - About - Disclaimer - Privacy